Detection of antibody-mediated reduction of annexin A5 anticoagulant activity in plasmas of patients with the antiphospholipid syndrome.

Blood
J RandThomas L Ortel

Abstract

Annexin A5 (A5) forms 2-dimensional crystals over phospholipid bilayers, blocking their availability for coagulation reactions. Recently, human antiphospholipid (aPL) monoclonal antibodies (mAbs) have been demonstrated by atomic force microscopy (AFM) to disrupt this crystallization and accelerate coagulation. We therefore performed a study with small, well-defined groups of patients to investigate whether these effects on A5 binding and activity are also detectable in plasmas from patients with the aPL syndrome. A5 binding to phospholipid was significantly reduced by plasmas of patients with the aPL syndrome and thromboembolism compared with healthy controls (mean +/- SD, 26.7 +/- 4.3 ng/well [n = 25] vs 30.5 +/- 3.1 ng/well [n = 20], P < .01) and the non-aPL thromboembolism group (29.9 +/- 3.2 ng/well [n = 15], P < .05). A5 anticoagulant activity was reduced by plasmas of patients with aPL syndrome and thromboembolism compared with aPL antibodies without thrombosis (182 +/- 31% [n = 25] vs 210 +/- 35% [n = 26], P < .01), non-aPL thromboembolism (229 +/- 16% [n = 15], P < .001), and healthy controls (231 +/- 14% [n = 30], P < .001). In conclusion, in accordance with recent AFM data with monoclonal human aPL antibodies, plasmas...Continue Reading

Citations

Feb 21, 2008·Nature Clinical Practice. Rheumatology·Bas de LaatPhilip G de Groot
Jun 15, 2013·Human Reproduction Update·Paulien G de JongSaskia Middeldorp
Mar 19, 2013·Rheumatology·Rabih NayfeMunther A Khamashta
Jan 22, 2009·Journal of Neuroinflammation·Lawrence L HorstmanAlireza Minagar
Jul 4, 2013·Southern Medical Journal·Pramod Reddy
Jan 7, 2014·Current Rheumatology Reports·Cecilia Beatrice ChighizolaPier Luigi Meroni
Jul 16, 2014·Current Opinion in Hematology·Shruti Chaturvedi, Keith R McCrae
Aug 1, 2013·Expert Review of Clinical Immunology·Bassem N MattaMunther A Khamashta
Apr 10, 2012·Micron : the International Research and Review Journal for Microscopy·Anthony S QuinnDouglas J Taatjes
Nov 22, 2011·La Revue de médecine interne·J Masliah-Planchon, L Darnige
Mar 4, 2008·Methods : a Companion to Methods in Enzymology·Gabriela BrumattiSeamus J Martin
Jul 15, 2005·Annals of the New York Academy of Sciences·N BizzaroD Villalta
Sep 26, 2007·Annals of the New York Academy of Sciences·Anna Cederholm, Johan Frostegård
Apr 5, 2012·American Journal of Hematology·Thomas L Ortel
Feb 24, 2011·British Journal of Clinical Pharmacology·Cornelis Kluft, Jacobus Burggraaf
Jul 26, 2011·American Journal of Obstetrics and Gynecology·Beverley J HuntJacob H Rand
Feb 18, 2016·Reproduction : the Official Journal of the Society for the Study of Fertility·Priyadarshini PanthamLawrence W Chamley
Dec 8, 2015·Hematology·Shruti Chaturvedi, Keith R McCrae
Oct 6, 2016·Clinical Rheumatology·Avital AvrielMahmoud Abu-Shakra
May 22, 2013·Lupus·D M WaheziUNKNOWN Atherosclerosis Prevention in Pediatric Lupus Erythematosus Investigators
Dec 17, 2011·The Journal of Rheumatology·Dawn M WaheziJacob H Rand
Sep 4, 2015·Physiological Reviews·Sandra T Cooper, Paul L McNeil
Sep 21, 2006·Blood·Bill GiannakopoulosSteven A Krilis
Oct 18, 2014·Clinical Chemistry and Laboratory Medicine : CCLM·Katrien M J DevreeseJoris R Delanghe
Jun 20, 2018·International Journal of Molecular Sciences·Sebastian SchloerUrsula Rescher

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.